Lemonade (LMND) Stock Falls Below $65—Is Now a Buy?

Lemonade (LMND) closed at $64.82 on March 7, 2026, marking a 7.3% decline over the past week and a 22% drop from its 52-week high of $83.45. The decline follows a mixed earnings report released on February 25, which showed a 14% year-over-year increase in revenue to $182 million, but a wider net loss of $64 million, compared to $42 million in the same quarter of the prior year. Despite strong customer acquisition—adding 185,000 new policyholders in Q4—the company reported a 21% increase in operating expenses, driven by technology and marketing spend. The stock’s valuation remains elevated relative to peers, with a price-to-sales ratio of 4.7x, compared to the 3.1x average for digital insurance firms such as Root (ROOT) and Allstate (ALL). Analysts are divided: six maintain a 'Buy' rating with a median price target of $81, citing long-term growth potential in AI-driven underwriting, while four have a 'Hold' rating, warning that sustained losses and high burn rates may pressure liquidity. Investor attention is also shifting toward the company’s upcoming capital raise, expected in Q2 2026, which could influence share pricing. With $430 million in cash reserves as of year-end 2025, Lemonade has approximately 18 months of runway at current spending levels. Market participants are watching the next earnings call for clarity on cost discipline and path to profitability. The broader insurance technology sector has seen a 12% correction since January, with LMND underperforming the S&P 500 by 18 percentage points. Retail investors, who own roughly 58% of outstanding shares, are actively trading the stock during the dip, driving increased volume on the NYSE.